Document Detail


Double-blind comparative clinical trial of pimozide and chlorpromazine in mania. A test of the dopamine hypothesis.
MedLine Citation:
PMID:  7051755     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pimozide (PMZ), a relatively specific dopamine (DA) receptor blocking drug, was compared to chlorpromazine (CPZ) in a double-blind, between-patient clinical trial in mania. The trial lasted 14 days. Twenty-three patients who fulfilled Feighner's criteria for mania entered the trial (one patient entering on two separate occasions). Both drugs led to clinical improvement, with a significant effect being noted within 24 hours. According to one of the two rating scales used, initial improvement was greater with chlorpromazine, probably due to its greater sedative effect. By 7 days both drugs were equally effective. Sedative side effects were more frequent in patients on CPZ; extrapyramidal side effects were more frequent with PMZ. The finding that the relatively specific DA receptor blocking drug PMZ was as effective as CPZ in the treatment of mania is consistent with the view that hyperactivity of central DA pathways is involved in the pathogenesis of this condition.
Authors:
J Cookson; T Silverstone; B Wells
Related Documents :
6233635 - Double blind study comparing the efficacy of zimelidine and amitriptyline in endogenous...
11154865 - Effects of cetirizine and epinastine on the skin response to histamine iontophoresis.
781835 - Effect of bromhexine and guaiphenesine on clinical state, ventilatory capacity and sput...
19856285 - Effect of dihydralazine on the fluidity of erythrocyte membranes.
20054425 - Hedonic homeostatic dysregulation as a driver of drug-seeking behavior.
20577875 - Risk management plans: are they a tool for improving drug safety?
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta psychiatrica Scandinavica     Volume:  64     ISSN:  0001-690X     ISO Abbreviation:  Acta Psychiatr Scand     Publication Date:  1981 Nov 
Date Detail:
Created Date:  1982-10-21     Completed Date:  1982-10-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370364     Medline TA:  Acta Psychiatr Scand     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  381-97     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Affective Disorders, Psychotic / drug therapy*
Aged
Bipolar Disorder / drug therapy*
Chlorpromazine / therapeutic use*
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Male
Middle Aged
Pimozide / therapeutic use*
Psychiatric Status Rating Scales
Receptors, Dopamine / drug effects*
Chemical
Reg. No./Substance:
0/Receptors, Dopamine; 2062-78-4/Pimozide; 50-53-3/Chlorpromazine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Insulin secretion during acid-base alterations. III: Role of extracellular calcium on the blocking e...
Next Document:  Coffee consumption, cigarette smoking and reporting of drowsiness in anxious patients treated with b...